<VariationArchive VariationID="1068813" VariationName="NM_004656.4(BAP1):c.1991del (p.Asp664fs)" VariationType="Deletion" Accession="VCV001068813" Version="5" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-07-15" DateCreated="2021-05-10" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1059871" VariationID="1068813">
      <GeneList>
        <Gene Symbol="BAP1" FullName="BRCA1 associated deubiquitinase 1" GeneID="8314" HGNC_ID="HGNC:950" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>3p21.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="52401008" stop="52410008" display_start="52401008" display_stop="52410008" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="52435023" stop="52444008" display_start="52435023" display_stop="52444008" Strand="-" />
          </Location>
          <OMIM>603089</OMIM>
          <Haploinsufficiency last_evaluated="2019-12-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=BAP1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2019-12-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=BAP1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_004656.4(BAP1):c.1991del (p.Asp664fs)</Name>
      <CanonicalSPDI>NC_000003.12:52402666:T:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>3p21.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="52402667" stop="52402667" display_start="52402667" display_stop="52402667" variantLength="1" positionVCF="52402666" referenceAlleleVCF="GT" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="52436683" stop="52436683" display_start="52436683" display_stop="52436683" variantLength="1" positionVCF="52436682" referenceAlleleVCF="GT" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>D664fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.52436683del" Assembly="GRCh37">
            <Expression>NC_000003.11:g.52436683del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.52402667del" Assembly="GRCh38">
            <Expression>NC_000003.12:g.52402667del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_031859.1" sequenceAccession="NG_031859" sequenceVersion="1" change="g.12327del">
            <Expression>NG_031859.1:g.12327del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004656.4" sequenceAccession="NM_004656" sequenceVersion="4" change="c.1991del" MANESelect="true">
            <Expression>NM_004656.4:c.1991del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004647.1" sequenceAccession="NP_004647" sequenceVersion="1" change="p.Asp664fs">
            <Expression>NP_004647.1:p.Asp664fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_529" sequenceAccession="LRG_529">
            <Expression>LRG_529:g.12327del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_529t1" sequenceAccession="LRG_529t1">
            <Expression>LRG_529t1:c.1991del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2153226220" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004656.4(BAP1):c.1991del (p.Asp664fs) AND BAP1-related tumor predisposition syndrome" Accession="RCV001380483" Version="3">
        <ClassifiedConditionList TraitSetID="7637">
          <ClassifiedCondition DB="MedGen" ID="C3280492">BAP1-related tumor predisposition syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-10-29" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004656.4(BAP1):c.1991del (p.Asp664fs) AND Hereditary cancer-predisposing syndrome" Accession="RCV002420856" Version="2">
        <ClassifiedConditionList TraitSetID="13598">
          <ClassifiedCondition DB="MedGen" ID="C0027672">Hereditary cancer-predisposing syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-12-03" SubmissionCount="1">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-12-03" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2021-05-10" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
        <Description>Conflicting classifications of pathogenicity</Description>
        <Explanation DataSource="ClinVar" Type="public">Pathogenic(1); Uncertain significance(1)</Explanation>
        <Citation Type="general">
          <ID Source="PubMed">21874000</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24243779</ID>
        </Citation>
        <Comment DataSource="ClinVar" Type="public">Pathogenic(1); Uncertain significance(1)</Comment>
        <DescriptionHistory Dated="2022-11-28">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="13598" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18746" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Hereditary Cancer Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Tumor predisposition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cancer predisposition</ElementValue>
                <XRef ID="Hereditary+Cancer/3345" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary neoplastic syndrome</ElementValue>
                <XRef ID="MONDO:0015356" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Neoplastic Syndromes, Hereditary</ElementValue>
                <XRef ID="D009386" DB="MeSH" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary cancer-predisposing syndrome</ElementValue>
                <XRef ID="699346009" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="19921" />
                <XRef ID="19921" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="IARC, 2008">
                <ID Source="pmc">3075918</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <XRef ID="140162" DB="Orphanet" />
              <XRef ID="C0027672" DB="MedGen" />
              <XRef ID="D009386" DB="MeSH" />
              <XRef ID="MONDO:0015356" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="7637" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16619" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">BAP1 tumor predisposition syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Tumor susceptibility linked to germline BAP1 mutations</ElementValue>
                <XRef ID="289539" DB="Orphanet" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">COMMON Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">TUMOR PREDISPOSITION SYNDROME 1</ElementValue>
                <XRef Type="MIM" ID="614327" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603089.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603089.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603089.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603089.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603089.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603089.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603089.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603089.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603089.0015" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603089.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603089.0003" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Tumor predisposition syndrome</ElementValue>
                <XRef ID="TUMOR+PREDISPOSITION+SYNDROME/9432" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">BAP1-related tumor predisposition syndrome</ElementValue>
                <XRef ID="MONDO:0013692" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">TPDS1</ElementValue>
                <XRef Type="MIM" ID="614327" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">TPDS</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">BAP1 tumor predisposition syndrome (BAP1-TPDS) is associated with an increased risk for a specific skin lesion, BAP1-inactivated melanocytic tumors (BIMT; formerly called atypical Spitz tumors), and the following cancers, in descending order of frequency: uveal (eye) melanoma (UM), malignant mesothelioma (MMe), cutaneous melanoma (CM), renal cell carcinoma (RCC), and basal cell carcinoma (BCC). Hepatocellular carcinoma, cholangiocarcinoma, and meningioma may also be associated with BAP1-TPDS. Affected individuals can have more than one type of primary cancer. In general, the median age of onset of these tumors is younger than in the general population. UM tends to be a more aggressive class 2 tumor with higher risk for metastasis and reduced survival compared to UM occurring in the general population. Due to the limited number of families reported to date, the penetrance, natural history, and frequencies of BAP1-associated tumors are yet to be determined. Other suspected but unconfirmed tumors in BAP1-TPDS include (in alphabetic order): breast cancer, neuroendocrine carcinoma, non-small-cell lung adenocarcinoma, thyroid cancer, and urinary bladder cancer.</Attribute>
                <XRef ID="NBK390611" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="13219" />
                <XRef ID="13219" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">27748099</ID>
                <ID Source="BookShelf">NBK390611</ID>
              </Citation>
              <XRef ID="289539" DB="Orphanet" />
              <XRef ID="C3280492" DB="MedGen" />
              <XRef ID="MONDO:0013692" DB="MONDO" />
              <XRef Type="MIM" ID="614327" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3104165" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="10074039|MedGen:C3280492" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001578565" DateUpdated="2024-02-28" DateCreated="2021-05-10" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-10-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21874000</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24243779</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the BAP1 protein in which other variant(s) (p.Gln684*) have been determined to be pathogenic (PMID: 21874000, 24243779). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 1068813). This variant has not been reported in the literature in individuals affected with BAP1-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Asp664Alafs*28) in the BAP1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 66 amino acid(s) of the BAP1 protein.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BAP1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000003.11:g.52436683del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3280492" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12974844</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5207857" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2022-11-29">
        <ClinVarSubmissionID localKey="a8256926|MedGen:C0027672" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002718574" DateUpdated="2024-05-01" DateCreated="2022-11-29" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-12-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Comment>The c.1991delA variant, located in coding exon 16 of the BAP1 gene, results from a deletion of one nucleotide at nucleotide position 1991, causing a translational frameshift with a predicted alternate stop codon (p.D664Afs*28). This alteration occurs at the 3' terminus of theBAP1 gene, is not expected to trigger nonsense-mediated mRNAdecay, and only impacts the last 65 amino acids of the protein. The exact functional effect of this alteration is unknown. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BAP1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004656.2:c.1991delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0027672" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5207857" TraitType="Disease" MappingType="XRef" MappingValue="C0027672" MappingRef="MedGen">
        <MedGen CUI="C0027672" Name="Hereditary cancer-predisposing syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3104165" TraitType="Disease" MappingType="XRef" MappingValue="C3280492" MappingRef="MedGen">
        <MedGen CUI="C3280492" Name="BAP1-related tumor predisposition syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

